trial
as of 2026-07-01Network-Targeted Neuromodulation for Nicotine Dependence in Schizophrenia
NCTId NCT06389266
at a glance
— · Completed
Enrollment 90 (actual)
Sponsored by Vanderbilt University Medical Center
Primary completion 2025-09-15
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
90 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
None
Start
2023-06-15
Primary completion
2025-09-15
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Vanderbilt University Medical CenterLead Sponsor
Investigators
1
Heather B Ward, MDPrincipal Investigator
Sites
1 total
Nashville, United States
Facts & assertions
4 sourced
Enrollment
90
Phase
NA
Primary Completion Date
2025-09-15
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
indication
investigator
person